This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
TriMas (TRS) Down 10.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) Q4 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Robust demand in TriMas' (TRS) Packaging segment led to improved fourth-quarter revenues. It is expected to drive 4% to 9%% year over year growth in first-quarter 2021 revenues.
TriMas (TRS) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here' Why Hold Strategy is Apt for TriMas (TRS) Stock
by Zacks Equity Research
A strong pipeline of product and process innovation, and acquisitions are some factors that make TriMas (TRS) stock worth retaining in the portfolio.
TriMas (TRS) Hits 52-Week High: What's Driving the Upside?
by Zacks Equity Research
Impressive third-quarter 2020 results, robust packaging demand and solid growth projections are contributing to the run up in TriMas' (TRS) shares.
Northwest Pipe (NWPX) Catches Eye: Stock Jumps 5.6%
by Zacks Equity Research
Northwest Pipe (NWPX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
TriMas (TRS) Acquires Affaba & Ferrari, Expands Product Offering
by Zacks Equity Research
The latest acquisition will help TriMas (TRS) strengthen its existing food and beverage, and industrial product lines.
GrafTech (EAF) Offers Senior Notes, To Use Funds for Loan Payments
by Zacks Equity Research
GrafTech (EAF) prices senior notes offerings worth $500 million and intends to use part of funds for loan payments under credit facility.
4 Top Industrial Stocks Set to Finish 2020 on a Stellar Note
by Namrata Chatterjee
As the U.S. manufacturing sector continues to expand for the sixth straight month, we suggest four lucrative industrial stocks with positive growth projections for your portfolio.
TriMas (TRS) Rides on Coronavirus Induced Demand for Packaging
by Zacks Equity Research
TriMas' (TRS) Packaging group is riding on increasing demand for personal hygiene products, home and industrial cleaning, food and beverage, and pharmaceuticals amid the COVID-19 pandemic.
Timken's (TKR) Board Okays 4% Hike in Quarterly Dividend Rate
by Zacks Equity Research
Timken (TKR), in sync with its shareholder-friendly policies, hikes the quarterly dividend rate by 4% or 1 cent per share.
TriMas (TRS) Q3 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Robust demand in TriMas' (TRS) Packaging segment offset weakness in other markets, leading to higher third-quarter revenues. It is expected to drive 4% to 6% year-over-year growth in 2020 revenues.
TriMas (TRS) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 10.26% and 2.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate TriMas (TRS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Metal Fabrication Stocks Poised to Escape Industry Woes
by Madhurima Das
The COVID-19 pandemic has impacted the Zacks Metal Products - Procurement and Fabrication industry's end-markets. Timken (TKR), Worthington (WOR), TriMas (TRS) and AmpcoPittsburgh (AP) are thus relying on cost control and automation to increase efficiency.
Is TriMas (TRS) a Suitable Stock for Value Investors Now?
by Zacks Equity Research
Let's see if TriMas (TRS) stock is a good choice for value-oriented investors right now from multiple angles.
TriMas (TRS) Up 6.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NN to Divest Life Sciences Unit, To Pay Debts With Proceeds
by Zacks Equity Research
The divestment of NN's (NNBR) Life Sciences business will help it focus on high-growth opportunities in Mobile Solutions and Power Solutions divisions. Also, it will enable debt reduction and improvement in financial flexibility.
TriMas (TRS) Rides on Robust Demand for Packaging & Buyouts
by Zacks Equity Research
TriMas (TRS) is benefiting from cost-control efforts, gains from the TriMas Business Model and solid demand from the packaging segment.
TriMas (TRS) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
TriMas' (TRS) second-quarter revenues improved from the prior year driven by record sales in the Packaging segment and recent acquisitions.
Ball Corp (BLL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Ball Corp's (BLL) Q2 performance likely to reflect benefits from solid demand for aluminum packaging, cost-cutting actions and robust aerospace backlog.
Sealed Air (SEE) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Sealed Air's (SEE) second-quarter results are likely to reflect benefits from solid demand in food and e-commerce, as well as savings from its Reinvent SEE Strategy.
TriMas (TRS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 34.38% and 3.39%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Caterpillar (CAT) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Caterpillar's (CAT) second-quarter results likely to reflect the ongoing weakness in the manufacturing sector, and weak demand in its markets amid the coronavirus pandemic.
TriMas (TRS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
TriMas (TRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.